The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Print

Oral Session

Oral Session 1-15A B Cell Lymphoma: Molecular Mechanism/Therapeutic Target

Fri. Oct 11, 2019 9:00 AM - 10:00 AM No.15 (Tokyo International Forum, 7F G701)

Chair: Koichi Sugimoto (Dept of Hematol/Oncol, JR Tokyo General Hospital, Tokyo, Japan)

[OS1-15A-1] PAICS inhibition is a potential therapeutic strategy for c-MYC-positive DLBCL

Kohta Miyawaki1,2, Takuji Yamauchi1,3, Takeshi Sugio1, Kensuke Sasaki1, Hiroaki Miyoshi2, Simon Osborne4, Debbie Taylor4, Koichi Ohshima2, Koji Kato1, Takahiro Maeda3, Koichi Akashi1 (1.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2.Department of Pathology, School of Medicine, Kurume University, Kurume, Japan, 3.Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, 4.LifeArc, WC1H 9LT, London, United Kingdom)

[OS1-15A-2] Gene mutations and sites of involvement in duodenal-type follicular lymphoma

Kana Miyazaki1, Toshifumi Takeuchi1,2, Motoko Yamaguchi1, Naoko Asano3, Akihiko Sawaki1, Hiroshi Imai4, Ryoichi Ono5, Tetsuya Nosaka5, Kazuhiko Kobayashi2, Kyosuke Tanaka6, Naoyuki Katayama1 (1.Department of Hematology and Oncology, Mie University, Tsu, Japan, 2.Gastroenterology, Matsusaka Chuo General Hospital, Matsusaka, Japan, 3.Department of Molecular Diagnostics, Shinshu Medical Center, Suzaka, Japan, 4.Pathology Division, Mie University Hospital, Tsu, Japan, 5.Department of Microbiology and Molecular Genetics, Mie University, Tsu, Japan, 6.Department of Endoscopy, Mie University Hospital, Tsu, Japan)